OWENS DAVID (Chief Medical Officer) purchased 2.0% of their position (3K shares) of NEXALIN TECHNOLOGY, INC. on the open market
Open‑market purchase worth $7.7K — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 1/24/2025ACC: 0001829126-25-000368
DirectorOfficer· Chief Medical Officer
Since Sep 2022
+3K
Net shares
Net buyer
$7.7K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
3K acquired
Non-Derivative Transactions2
Common stock
Direct
Shares
+2K
Price / share
$2.50
Trade value
$5K
% of position
1.3%
1/13/2025
149.29K→151.29K
Common stock
Direct
Shares
+1K
Price / share
$2.70
Trade value
$2.70K
% of position
0.7%
1/23/2025
151.29K→152.29K
Total
Net shares
+3K
Net value
$7.70K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock Direct | 1/13/2025 | P · Purchase | +2K | $2.50 | $5K | 1.3% | 149.29K | 151.29K |
| Common stock Direct | 1/23/2025 | P · Purchase | +1K | $2.70 | $2.70K | 0.7% | 151.29K | 152.29K |
| Total | +3K | $7.70K | ||||||
Derivative Transactions0
No derivative transactions reported